#Opioids

New Medicaid Policy Will Help States Better Fight the Opioid Crisis

This is one of many ways that people who use drugs can engage in harm reduction during the coronavirus pandemic.

A national survey found that primary care physicians had little interest in prescribing buprenorphine or naltrexone.

Even after federal regulators relaxed rules requiring daily clinic visits, these bad actors are still bringing patients in for monitoring.

The coronavirus pandemic has upended the usual systems governing the dispensation of medication-assisted treatment.

The CDC calls for everyone to be tested and for all pregnant women to be tested during every pregnancy.

Prescriptions in the household have long been cited as a source of individuals’ misuse of opioids.

However, the overdose death rate resulting from synthetic opioids, especially fentanyl, rose between 2017 and 2018.

Just under 1% of pregnant women in the state overall up to 2% in central and western New York have hep C antibodies.

One bill would create 1,000 new residency positions for physicians going into addiction treatment medicine.

Teenagers are attempting suicide with opioids at increasing rates.

A systematic review of hep C treatment outcomes in this population shows they have high cure rates and relatively low reinfection rates.

A recent study found that providing opioid use disorder treatment was associated with a high hep C cure rate and less drug use.

A series of lawsuits have charged that chains like CVS, Rite Aid and Walgreens share blame for opioid overprescribing.

Current trends are reshaping the policy and public health landscapes, making harm reduction more urgent and relevant than ever before.

Federal judge rules in favor of nonprofit seeking to open the country’s first overdose prevention facility.

That sliver of physicians was also more inclined to prescribe doses of opioids higher and for longer than what the CDC recommends.